GoodRx Launches New ‘GoodRx for Hair Loss’ Subscription Service for Men

GoodRx Holdings Inc.  (NASDAQ:GDRX) is one of the best NASDAQ stocks under $5 to buy now. On October 15, GoodRx announced the launch of a new subscription service called GoodRx for Hair Loss designed to simplify access to affordable treatment for men. The subscription is an all-in-one solution for a health concern that affects about half of all men in the US by age 50, who experience some degree of thinning or baldness.

The service aims to overcome the difficulty many men face in pursuing treatment due to high costs, complicated routines, or uncertainty about effective options, despite treatments like oral finasteride and oral minoxidil being clinically proven, especially when started early. GoodRx for Hair Loss starts as low as $16 per month, with the final pricing depending on the specific prescribed medication and the delivery cadence chosen.

The subscription service bundles three key benefits. First, customers connect with a licensed healthcare professional online, often within an hour, without needing an in-person visit, and retain ongoing access for any treatment questions. Second, if appropriate following the consultation, customers receive a prescription for clinically-proven treatments, specifically oral finasteride or oral minoxidil. Third, the prescribed medication is delivered directly to the customer’s door, in GoodRx’s standard packaging, with no additional fee for discreet delivery.

GoodRx Holdings Inc.  (NASDAQ:GDRX), together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the US.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.